Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A peptidomimetic inhibitor of ras functionality markedly suppresses growth of human prostate tumor xenografts in mice. Prospects for long-term clinical utility
    Journal Article

    Sirotnak, F. M.; Sepp-Lorenzino, L.; Kohl, N. E.; Rosen, N.; Scher, H. I.
    Cancer Chemotherapy and Pharmacology (2000)

    Fulltext@MSK | Save
  • Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes
    Journal Article

    Barakat, R. R.; Federici, M. G.; Saigo, P. E.; Robson, M. E.; Offit, K.; Boyd, J.
    Cancer (2000)

    Fulltext@MSK | Save
  • A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: Cancer and Leukemia Group B study 9181
    Journal Article

    Dawson, N. A.; Conaway, M.; Halabi, S.; Winer, E. P.; Small, E. J.; Lake, D.; Vogelzang, N. J.
    Cancer (2000)

    Fulltext@MSK | Save
  • Synthesis and evaluation of geldanamycin-testosterone hybrids
    Journal Article

    Kuduk, S. D.; Harris, C. R.; Zheng, F. F.; Sepp-Lorenzino, L.; Ouerfelli, O.; Rosen, N.; Danishefsky, S. J.
    Bioorganic & Medicinal Chemistry Letters (2000)

    Fulltext@MSK | Save
  • Metastatic lobular carcinoma of the breast: Patterns of spread in the chest, abdomen, and pelvis on CT
    Journal Article

    Winston, C. B.; Hadar, O.; Teitcher, J. B.; Caravelli, J. F.; Sklarin, N. T.; Panicek, D. M.; Liberman, L.
    American Journal of Roentgenology (2000)

    Fulltext@MSK | Save
  • Case #H.12.1 - To discuss the use of hormone replacement therapy in a woman at high risk for breast cancer
    Book Section

    Norton, L.; Gilewski, T.
    In Hait, W. N.; August, D. A.; Haffty, B. G. (Eds.) Expert Consultations in Breast Cancer: Critical Pathways and Clinical Decision Making (1999)

    Fulltext@MSK | Save
  • Case #G.3 - Goal: To discuss the use of tumor markers in the management of metastatic disease
    Book Section

    Norton, L.; Gilewski, T.
    In Hait, W. N.; August, D. A.; Haffty, B. G. (Eds.) Expert Consultations in Breast Cancer: Critical Pathways and Clinical Decision Making (1999)

    Fulltext@MSK | Save
  • Case #D.2 - Goal: To discuss the use of neoadjuvant chemotherapy
    Book Section

    Norton, L.; Gilewski, T.
    In Hait, W. N.; August, D. A.; Haffty, B. G. (Eds.) Expert Consultations in Breast Cancer: Critical Pathways and Clinical Decision Making (1999)

    Fulltext@MSK | Save
  • A second opinion
    Book Section

    Norton, L.; Gilewski, T.
    In Hait, W. N.; August, D. A.; Haffty, B. G. (Eds.) Expert Consultations in Breast Cancer: Critical Pathways and Clinical Decision Making (1999)

    Fulltext@MSK | Save
  • Pharmacokinetics and pharmacodynamics of the farnesyl protein transferase inhibitor (L-778,123) in solid tumors
    Meeting Abstract

    Soignet, S.; Yao, S. L.; Britten, C.; Spriggs, D.; Pezzulli, S.; McCreery, H.; Mazina, K.; Deutsch, P.; Lee, Y.; Lobell, R.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save